Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NYSE - Nasdaq Real Time Price USD

Medtronic plc (MDT)

Compare
87.63
-0.65
(-0.74%)
At close: March 28 at 4:00:02 PM EDT
87.47
-0.16
(-0.18%)
After hours: March 28 at 7:56:20 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
33,199,000
32,364,000
31,227,000
31,686,000
30,117,000
Cost of Revenue
11,529,000
11,216,000
10,719,000
10,145,000
10,483,000
Gross Profit
21,670,000
21,148,000
20,508,000
21,541,000
19,634,000
Operating Expense
15,718,000
15,628,000
14,678,000
15,633,000
14,739,000
Operating Income
5,952,000
5,520,000
5,830,000
5,908,000
4,895,000
Net Non Operating Interest Income Expense
-757,000
-719,000
-636,000
-553,000
-925,000
Other Income Expense
28,000
37,000
170,000
163,000
-75,000
Pretax Income
5,222,000
4,837,000
5,364,000
5,517,000
3,895,000
Tax Provision
934,000
1,133,000
1,580,000
456,000
265,000
Net Income Common Stockholders
4,260,000
3,676,000
3,758,000
5,039,000
3,606,000
Diluted NI Available to Com Stockholders
4,260,000
3,676,000
3,758,000
5,039,000
3,606,000
Basic EPS
3.30
2.77
2.83
3.75
2.68
Diluted EPS
3.28
2.76
2.82
3.73
2.66
Basic Average Shares
1,295,150
1,327,700
1,329,800
1,342,400
1,344,900
Diluted Average Shares
1,298,850
1,330,200
1,332,800
1,351,400
1,354,000
Total Operating Income as Reported
5,572,000
5,144,000
5,485,000
5,752,000
4,484,000
Total Expenses
27,247,000
26,844,000
25,397,000
25,778,000
25,222,000
Net Income from Continuing & Discontinued Operation
4,260,000
3,676,000
3,758,000
5,039,000
3,606,000
Normalized Income
4,572,033.70
3,963,250
4,001,225
5,181,135
3,989,037.23
Interest Expense
757,000
719,000
636,000
553,000
925,000
Net Interest Income
-757,000
-719,000
-636,000
-553,000
-925,000
EBIT
5,979,000
5,556,000
6,000,000
6,070,000
4,820,000
EBITDA
8,654,000
8,203,000
8,697,000
8,777,000
7,522,000
Reconciled Cost of Revenue
10,516,000
10,262,000
9,720,000
9,171,000
9,564,000
Reconciled Depreciation
2,675,000
2,647,000
2,697,000
2,707,000
2,702,000
Net Income from Continuing Operation Net Minority Interest
4,260,000
3,676,000
3,758,000
5,039,000
3,606,000
Total Unusual Items Excluding Goodwill
-380,000
-375,000
-345,000
-155,000
-411,000
Total Unusual Items
-380,000
-375,000
-345,000
-155,000
-411,000
Normalized EBITDA
9,034,000
8,578,000
9,042,000
8,932,000
7,933,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-67,966.30
-87,750
-101,775
-12,865
-27,962.77
4/30/2021 - 5/2/1973

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BSX Boston Scientific Corporation
99.36
-1.43%
 
ABT Abbott Laboratories
130.82
-0.40%
 
SYK Stryker Corporation
364.50
-0.83%
 
EW Edwards Lifesciences Corporation
70.91
-0.39%
 
DXCM DexCom, Inc.
67.74
-2.49%
 
ZBH Zimmer Biomet Holdings, Inc.
112.26
+0.10%
 
PHG Koninklijke Philips N.V.
25.64
-0.19%
 
TMDX TransMedics Group, Inc.
68.58
-2.64%
 
PODD Insulet Corporation
258.75
-0.58%
 
GMED Globus Medical, Inc.
72.55
-1.51%